
08/02/2025
We are pleased to announce the acquisition of our second Neurostar system. Utilizing this treatment for our patients over the past decade has been a remarkable and rewarding experience, yielding outstanding results for numerous individuals. South TX TMS is now equipped to support a greater number of community members struggling with Major Depression. Furthermore, we are excited about the FDA indication for OCD and Adolescent Depression. We appreciate Lindsey Delosier, Neurostar Traveling Practice Development Manager, for meeting with our TMS coordinator Judi and myself today. This meeting provided a valuable opportunity to enhance our skills as we move into 2025. If you are struggling with Depression, Anxiety, or OCD, please do not hesitate to contact us. We are committed to serving your needs.